Loading...

Intelligent Bio Solutions Inc.

INBS•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.55
$-0.08(-3.04%)
U.S. Market opens in 23h 5m

Intelligent Bio Solutions Inc. (INBS) Stock Overview

Explore Intelligent Bio Solutions Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E Ratio-0.22
EPS (TTM)$-14.45
ROE-1.98%
Fundamental Analysis

AI Price Forecasts

1 Month$2.67
3 Months$6.29
1 Year Target$0.00

INBS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Intelligent Bio Solutions Inc. (INBS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.22 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.04%
5-Day Change
-8.93%
1-Month Change
-22.49%
3-Month Change
-73.19%
6-Month Change
-74.75%
Year-to-Date (YTD) Change
-73.24%
1-Year Change
-80.38%
3-Year Change
-99.31%
5-Year Change
-99.98%
All-Time (Max) Change
-99.99%

Contact Information

https://gbs.inc
646 828 8258
142 West 57th Street, New York City, NY, 10019

Company Facts

50 Employees
IPO DateDec 23, 2020
CountryUS
Actively Trading

Frequently Asked Questions